ARCHIVES

BMI May Be Prognostic Tool For Types Of Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

DCT Board Approves Drug Development Recompetition

November 30, 1990

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980

NTP Board Plans Peer Review Of Bioassay Reports

April 11, 1980

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013